Issue 60, 2016

A novel anticancer theranostic pro-prodrug based on hypoxia and photo sequential control

Abstract

A novel anticancer pro-prodrug (GMC-CAE-NO2) with diagnosis and therapy functions based on hypoxia and photo sequential control was designed. It provides a platform for constructing theranostic pro-prodrugs to release active drugs controlled by hypoxic status and UV illumination.

Graphical abstract: A novel anticancer theranostic pro-prodrug based on hypoxia and photo sequential control

Supplementary files

Article information

Article type
Communication
Submitted
08 Apr 2016
Accepted
20 Jun 2016
First published
23 Jun 2016

Chem. Commun., 2016,52, 9434-9437

A novel anticancer theranostic pro-prodrug based on hypoxia and photo sequential control

W. Feng, C. Gao, W. Liu, H. Ren, C. Wang, K. Ge, S. Li, G. Zhou, H. Li, S. Wang, G. Jia, Z. Li and J. Zhang, Chem. Commun., 2016, 52, 9434 DOI: 10.1039/C6CC02932A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements